Effectiveness of Neurofeedback on psychological stress

Not Applicable

Conditions: F43.0
Condition 1: Anxiety. Condition 2: stress.
Anxiety disorder due to known physiological condition
Acute stress reaction
F06.4

Registration Number: IRCT20190602043790N3

Lead Sponsor: Bagheiat-allah University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 60

Inclusion Criteria

Achieving a score above 18 on the stress scale of the Stress, Anxiety and Depression Questionnaire (DASS-21)
Age range between 18 to 25 years old

Exclusion Criteria

Presence or history of severe psychiatric disorders (including periods of severe depression, anxiety disorders, substance use disorders)
Smoking and psychedelic pills
Using psychiatric drugs
Epilepsy
Various cardiovascular and respiratory disorders and blood pressure
Aspirin use and acetaminophen over the past 48 hours
history of cancer
diabetes
hypothyroidism or hyperthyroidism
Addison disease
Cushing's syndrome
hypertension
Use of corticosteroids and steroids

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Anxiety symptoms. Timepoint: At the beginning of the study (before the intervention), weeks 5 and 10 after the start of neurofeedback in intervention group. Method of measurement: Stress, anxiety and depression scales (DASS-21).;Stress. Timepoint: At the beginning of the study (before the intervention), weeks 5 and 10 after the start of neurofeedback in intervention group. Method of measurement: Stress, anxiety and depression scales (DASS-21).;Cortisol. Timepoint: At the beginning of the study (before the intervention), weeks 5 and 10 after the start of neurofeedback in intervention group. Method of measurement: Stress, anxiety and depression scales (DASS-21).;a amylase. Timepoint: At the beginning of the study (before the intervention), weeks 5 and 10 after the start of neurofeedback in intervention group. Method of measurement: Stress, anxiety and depression scales (DASS-21).

Secondary Outcome Measures